AI in Drug Discovery Market Size to Worth USD 17.56 Billion by 2031, at a CAGR of 28.1% – MarketsandMarkets™

Delray Beach, FL, Oct. 16, 2026 -- MarketsandMarkets™ projects the global AI in drug discovery market to grow from USD 5.09 billion in 2026 to USD 17.56 billion by 2031, at a CAGR of 28.1% during the forecast period. Market growth is driven by the growing pharmaceutical demand to reduce drug discovery timelines and R&D costs, increasing adoption of generative AI and foundation models, expanding availability of multi-omics datasets, and investments in AI-enabled drug discovery platforms. Increasing strategic collaborations between pharmaceutical companies and AI technology providers, coupled with advances in cloud computing, high-performance computing, and computational biology, are further boosting the adoption of AI across early-stage drug discovery.